Document Detail


A freeze-injured skin graft model for the quantitative study of basic fibroblast growth factor and other promoters of angiogenesis in wound healing.
MedLine Citation:
PMID:  7522103     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A new in vivo model has been developed for the quantitative study of promoters and potential promoters of angiogenesis. Full thickness rat skin autografts received a reproducible and uniform freeze injury, before being applied to full thickness wounds, in order to delay revascularisation. Blood flow in the grafts was measured during the healing period using noninvasive (laser Doppler flowmetry) and invasive (133Xe clearance) techniques. The increase in blood flow over a period of 10-14 days was taken as an index of angiogenesis. These measurements were corroborated by histological assessment of the graft vasculature, using a laminin stain to highlight vascular basement membrane. Freeze injury delayed but did not ultimately prevent full graft revascularisation (p < 0.01 for laser Doppler flowmetry and 133Xe clearance). Application of the angiogenic agent basic fibroblast growth factor (bFGF), in slow release pellet form, stimulated angiogenesis in cryoinjured grafts in a dose-related fashion. Doses of 500 and 5000 ng bFGF produced significant stimulation (500 ng bFGF, p < 0.001, and 5000 ng bFGF, p < 0.01, for both laser Doppler flowmetry and 133Xe clearance; increased vessel profile counts, p < 0.05, at each time point tested for both doses) while 50 ng bFGF had no significant effect. By contrast, 500 ng bFGF had no measurable effect on uninjured grafts. In addition, bFGF-stimulated angiogenesis in cryoinjured grafts was antagonised by a neutralising antibody to bFGF, demonstrating the specificity of action of bFGF in this model.
Authors:
V C Lees; T P Fan
Related Documents :
3332633 - The influence of patent branches on in situ vein graft haemodynamics.
1098233 - Comparison of blood flow and patency in arterial and vein grafts to basilar artery.
18799893 - Archived unfrozen neonatal blood spots are amenable to quantitative gene expression ana...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of plastic surgery     Volume:  47     ISSN:  0007-1226     ISO Abbreviation:  Br J Plast Surg     Publication Date:  1994 Jul 
Date Detail:
Created Date:  1994-10-17     Completed Date:  1994-10-17     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  2984714R     Medline TA:  Br J Plast Surg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  349-59     Citation Subset:  IM    
Affiliation:
University Department of Pharmacology, Cambridge, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies, Monoclonal
Cold Temperature / adverse effects*
Delayed-Action Preparations
Disease Models, Animal*
Dose-Response Relationship, Drug
Fibroblast Growth Factor 2 / administration & dosage,  immunology,  metabolism*,  pharmacology
Male
Neovascularization, Pathologic / physiopathology*
Rats
Rats, Wistar
Skin Transplantation*
Transplantation, Autologous
Wound Healing / physiology*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Delayed-Action Preparations; 103107-01-3/Fibroblast Growth Factor 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of endothelial cell adhesion molecules in human bronchial xenografts.
Next Document:  Competitive antagonism by phenylglycine derivatives at type I metabotropic glutamate receptors.